IL6 and endometrial cancer: Strikingly, the correlation between ROS and IL-6, and between ROS and stage of disease, has been found in both type I and II endometrial cancer patients, thus substantiating the evidence showing that metastatic disease and chronic inflammation are associated with ROS independently from adiposity.